⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 15, 2024

Supplemental Table 2 from Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy

Molly E. Heft Neal Catherine T. Haring Emily L. Bellile Craig C. Jaffe Andrew G. Shuman Steven B. Chinn Chaz L. Stucken Kelly M. Malloy Keith Casper Mark E. Prince Douglas B. Chepeha Andrew J. Rosko Matthew E. Spector

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplemental Table 2: Initial tumor and nodal staging for patients stratified by post-operative thyroid status, fistula, and fistula requiring OR. Fischer’s exact test was used to compare each group.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Neal et al. (2024) studied this question.

synapsesocial.com/papers/68e60477b6db643587598442 https://doi.org/10.1158/1078-0432.26302488.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table 2 from Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy2024
2Supplemental Table 1 from Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy2024
3Supplemental Table 1 from Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy2024
4Supplemental Figure 1 from Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy2024
5Supplemental Figure 1 from Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy2024